BACKGROUND AND PURPOSE: The human, rat, and mouse P2X(7) receptors have been previously characterized, and in this study we report the cloning and pharmacological properties of the guinea pig orthologue. EXPERIMENTAL APPROACH: A cDNA encoding for the guinea pig P2X(7) receptor was isolated from a guinea pig brain library. The receptor was expressed in U-2 OS cells using the BacMam viral expression system. A monoclonal antibody was used to confirm high levels of cell surface expression and the functional properties were determined in ethidium bromide accumulation studies. KEY RESULTS: The predicted guinea pig protein is one amino acid shorter than the human and rat orthologues and over 70% identical to the rat and human receptors. In contrast to human and rat P2X(7) receptors, 2'-&3'-O-(4benzoylbenzoyl)ATP (BzATP) was a partial agonist of the guinea pig P2X(7) receptor when compared to ATP and acted as an antagonist in some assays. However, as at other species orthologues, BzATP was more potent than ATP. The guinea pig P2X(7) receptor possessed higher affinity for 1-[N,O-bis(5-isoquinoline sulphonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine (KN62), suramin and Coomassie Brilliant Blue than human or rat P2X(7) receptors suggesting that it is pharmacologically different to other rodent or human P2X(7) receptors. CONCLUSIONS AND IMPLICATIONS: The guinea pig recombinant P2X(7) receptor displays a number of unique properties that differentiate it from the human, rat and mouse orthologues and this structural and functional information should aid in our understanding of the interaction of agonists and antagonist with the P2X(7) receptor.
BACKGROUND AND PURPOSE: The human, rat, and mouse P2X(7) receptors have been previously characterized, and in this study we report the cloning and pharmacological properties of the guinea pig orthologue. EXPERIMENTAL APPROACH: A cDNA encoding for the guinea pigP2X(7) receptor was isolated from a guinea pig brain library. The receptor was expressed in U-2 OS cells using the BacMam viral expression system. A monoclonal antibody was used to confirm high levels of cell surface expression and the functional properties were determined in ethidium bromide accumulation studies. KEY RESULTS: The predicted guinea pig protein is one amino acid shorter than the human and rat orthologues and over 70% identical to the rat and human receptors. In contrast to human and rat P2X(7) receptors, 2'-&3'-O-(4benzoylbenzoyl)ATP (BzATP) was a partial agonist of the guinea pigP2X(7) receptor when compared to ATP and acted as an antagonist in some assays. However, as at other species orthologues, BzATP was more potent than ATP. The guinea pigP2X(7) receptor possessed higher affinity for 1-[N,O-bis(5-isoquinoline sulphonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine (KN62), suramin and Coomassie Brilliant Blue than human or rat P2X(7) receptors suggesting that it is pharmacologically different to other rodent or human P2X(7) receptors. CONCLUSIONS AND IMPLICATIONS: The guinea pig recombinant P2X(7) receptor displays a number of unique properties that differentiate it from the human, rat and mouse orthologues and this structural and functional information should aid in our understanding of the interaction of agonists and antagonist with the P2X(7) receptor.
Authors: B J Gu; W Zhang; R A Worthington; R Sluyter; P Dao-Ung; S Petrou; J A Barden; J S Wiley Journal: J Biol Chem Date: 2001-01-09 Impact factor: 5.157
Authors: James S Wiley; Lan-Phuong Dao-Ung; Changping Li; Anne N Shemon; Ben J Gu; Megan L Smart; Stephen J Fuller; Julian A Barden; Steven Petrou; Ronald Sluyter Journal: J Biol Chem Date: 2003-02-13 Impact factor: 5.157
Authors: Jeffrey L Pfohl; Jennings F Worley; J Patrick Condreay; Gang An; Christopher J Apolito; Tom A Kost; James F Truax Journal: Receptors Channels Date: 2002
Authors: Loren C Denlinger; Julie A Sommer; Karen Parker; Lalitha Gudipaty; Philip L Fisette; Jyoti W Watters; Richard A Proctor; George R Dubyak; Paul J Bertics Journal: J Immunol Date: 2003-08-01 Impact factor: 5.422
Authors: A D Michel; W C Clay; S W Ng; S Roman; K Thompson; J P Condreay; M Hall; J Holbrook; D Livermore; S Senger Journal: Br J Pharmacol Date: 2008-07-28 Impact factor: 8.739
Authors: S Roman; F S Cusdin; E Fonfria; J A Goodwin; J Reeves; S C Lappin; L Chambers; D S Walter; W C Clay; A D Michel Journal: Br J Pharmacol Date: 2009-10-08 Impact factor: 8.739
Authors: Anton D Michel; Sin-Wei Ng; Shilina Roman; William C Clay; David K Dean; Daryl S Walter Journal: Br J Pharmacol Date: 2009-03-20 Impact factor: 8.739
Authors: April Goehring; Chia-Hsueh Lee; Kevin H Wang; Jennifer Carlisle Michel; Derek P Claxton; Isabelle Baconguis; Thorsten Althoff; Suzanne Fischer; K Christopher Garcia; Eric Gouaux Journal: Nat Protoc Date: 2014-10-09 Impact factor: 13.491